Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 1,175 | 1,717 | 1,305 | 1,004 | 1,247 |
| Cost of Goods | 505 | 705 | 580 | 477 | 553 |
| Gross Profit | 671 | 1,013 | 740 | 526 | 695 |
| Operating Expenses | 1,138 | 1,436 | 1,577 | 1,196 | 1,680 |
| Operating Income | 37 | 281 | -272 | -192 | -433 |
| Other Income | -10 | -11 | 275 | -19 | -24 |
| Pre-tax Income | 27 | 271 | 3 | -211 | -457 |
| Income Tax | 12 | 116 | 3 | -83 | -198 |
| Net Income Continuous | 15 | 155 | -1 | -128 | -258 |
| Net Income | $15 | $155 | $-1 | $-128 | $-258 |
| EPS Basic Total Ops | 0.01 | 0.05 | N/A | -0.04 | -0.09 |
| EPS Basic Continuous Ops | 0.01 | 0.05 | 0.00 | -0.04 | -0.09 |
| EPS Diluted Total Ops | 0.00 | 0.05 | N/A | -0.04 | -0.09 |
| EPS Diluted Continuous Ops | 0.00 | 0.05 | 0.00 | -0.04 | -0.09 |
| EBITDA(a) | $145 | $385 | $-173 | $-96 | $-325 |